Get started
Author

Vivek B. Maleyur

Observed names: V.B. Maleyur, Vivek B Maleyur, Vivek Basavaraj Maleyur, Vivek Maleyur
ORCID: 0000-0002-1439-4253
Observed ORCID: 0000-0002-1439-4253
OpenAlex ID: A5115053413
Genomic Analysis and Clinical Correlation of Non-Small Cell Lung Cancer with Special Reference to Brain Metastasis
2026 · A.H. Rudresha, Kartik Asutkar, et al. · Asian Pacific Journal of Cancer Prevention · 1
PDF
Cytogenetic Landscape and Clinical Profile of CML Patients Presenting in Blast Phase: an Ambispective Study from A Regional Cancer Centre in South India
2026 · Smitha C. Saldanha, Kartik Gajanan Asutkar, et al. · Indian Journal of Hematology and Blood Transfusion · 1
Clinicopathological Spectrum and Outcomes of Multiple Primary Malignancies: A Retrospective Study from a Tertiary Cancer Center
2026 · Rudresha AH, Kartik G. Asutkar, et al. · Indian Journal of Medical and Paediatric Oncology
Outcome and Toxicity with the Use of L-Asparaginase-Free Regimen in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Prospective Study from a Tertiary Care Hospital in South India
2026 · Vivek B. Maleyur, H. A. Rudresh, et al. · Indian Journal of Medical and Paediatric Oncology
Cytogenetic and Clinical Profile of CML Patients Presenting in Blast Crisis: Prospective Study from a Regional Cancer Center in South India
2026 · Kartik G. Asutkar, Smitha C. Saldanha, et al. · Indian Journal of Medical and Paediatric Oncology
Clinical Profile and Treatment Outcomes of Adult Non-Pulmonary Langerhans Cell Histiocytosis from a Tertiary Care Hospital in South India
2026 · A. H. Rudresha, Vivek B. Maleyur, et al. · Indian Journal of Hematology and Blood Transfusion
Clinico-pathological features and the role of CD4/CD8 lymphocyte ratio in predicting response to neoadjuvant FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy in locally advanced gastric cancer
2025 · Rudresha A H, Vivek Basavaraj Maleyur, et al. · Asian Journal of Oncology
PDF
Jejunal Extragonadal Germ Cell Tumor Presenting as an Abdominal Mass: A Case Report
2025 · Kartik G. Asutkar, Smitha C. Saldanha, et al. · Indian Journal of Medical and Paediatric Oncology
PDF
A Study to Evaluate the Role of Fractionated Cyclophosphamide With R-chop Chemo-immunotherapy in High Risk Dlbcl Patients.
2025 · Rudresha A H, Vivek B Maleyur, et al. · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
Study of Change in Systemic Immune-inflammation Index as a Response Predictor in Gastroesophageal Junction Cancer Post Neoadjuvant Chemotherapy
2025 · Rudresha A H, Kartik Gajanan Asutkar, et al. · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
1287P Fractionated cyclophosphamide with RCHOP therapy compared to standard RCHOP in high risk DLBCL patients
2025 · A.H. Rudresha, V.B. Maleyur, et al. · Annals of Oncology
3173eP Pan immune inflammation value (PIV) index as a predictive biomarker of response to immune checkpoint inhibitors in patients with advanced malignancy
2025 · A.H. Rudresha, V.B. Maleyur, et al. · Annals of Oncology
785P Cytogenetic and clinical profile of CML patients presenting in blast crisis: Prospective study from a regional cancer centre in South India
2024 · K.G. Asutkar, S.C. Saldanha, et al. · Annals of Oncology
PDF
Works count: 13
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type